{"id":"https://openalex.org/A5064693328","orcid":"https://orcid.org/0000-0001-9670-0383","observed_orcids":["https://orcid.org/0000-0001-9670-0383"],"display_name":"Thane Jones","raw_author_names":["Thane Jones"],"full_name":"Thane Jones","works_count":8,"cited_by_count":65,"summary_stats":{"2yr_mean_citedness":4.5,"h_index":5,"i10_index":4},"ids":{"openalex":"https://openalex.org/A5064693328","orcid":"https://orcid.org/0000-0001-9670-0383","observed_orcids":["https://orcid.org/0000-0001-9670-0383"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210148032","ror":"https://ror.org/04m718665","display_name":"Collaborations Pharmaceuticals (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I4210148032"]},"years":[2025,2024,2023]}],"last_known_institutions":[{"id":"https://openalex.org/I4210148032","ror":"https://ror.org/04m718665","display_name":"Collaborations Pharmaceuticals (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I4210148032"]}],"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","count":5,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","count":3,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","count":2,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11948","display_name":"Machine Learning in Materials Science","count":2,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","count":2,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","value":5.03e-05,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","value":1.48e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","value":1.23e-05,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","value":1.06e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11948","display_name":"Machine Learning in Materials Science","value":8.8e-06,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"x_concepts":[{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.6204953789710999},{"id":"98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","score":0.4912981390953064},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.46313124895095825},{"id":"86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","score":0.42117631435394287},{"id":"55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","score":0.2670794725418091}],"counts_by_year":[{"year":2023,"works_count":4,"oa_works_count":4,"cited_by_count":3},{"year":2024,"works_count":3,"oa_works_count":2,"cited_by_count":11},{"year":2025,"works_count":1,"oa_works_count":1,"cited_by_count":33},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":18}],"display_name_alternatives":["Thane Jones"],"block_key":"t jones","works_api_url":"https://api.openalex.org/works?filter=author.id:A5064693328","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5064693328","updated_date":"2026-11-10T14:30:39","created_date":"2023-05-03T00:00:00"}
